EULAR 2008 - Rheumatoid Arthritis : Other

The Annual European Congress of Rheumatology was held in Paris, France from June 11-14, 2008. This is the official meeting of the European League Against Rheumatism (EULAR). Full abstract reports may be can be found online by visiting the EULAR Congress website. While it is not possible to review all of the important findings from these meetings, some selected highlights are summarized. These highlights focus on Rheumatoid Arthritis. The highlights are summarized by Joan Bathon, M.D. and Jon Giles, M.D.

• OP-0041 – Joan Bathon A 3 Week Course of IM Steroid Injections May Prevent the Progression of Very Early Inflammatory Polyarthritis: Results of the STIVEA Trial.
• OP-0042 – Jon Giles New Modified-Release Prednisone Tablet Shows Sustained Reduction of Morning Stiffness and Interleukin-6 in Patients with Rheumatoid Arthritis
• OP-0044 – Joan Bathon Initial Efficacy of INCB018424, a Selective Janus Kinase 1&2 (JAK 1&2) Inhibitor in Rheumatoid Arthritis (RA)
• OP-0122 – Joan Bathon Preliminary Safety and Efficacy of Baminercept Alfa (BG9924, LTBR-IG) in the Treatment of Rheumatoid Arthritis (RA)
• OP-0124 – Joan Bathon ARRY-162, A Novel Inhibitor of MEK Kinase: Phase 1A-1B Pharmacokinetic and Pharmacodynamic Results.